The emergence of artificial intelligence (AI) in healthcare is the result of increased demand for tailored healthcare solutions, lower costs, higher accuracy pertaining to medical decisions and diagnosis to improve patient health outcomes.
With an estimated valuation of $15.1 billion for the global market in 2022, AI in healthcare is an irreversible process that is already reshaping medicine and...
Leaders in the digital health space told MobiHealthNews their predictions about where AI will make the most significant mark in healthcare in 2024.
Following the considerable increase in the use of AI in healthcare in 2023, stakeholders expect next year to bring even wider adoption of the technology across various sectors, from implementation in physician-facing tools that help ease provider...
Digital metabolic care startup Twin Health announced it has raised $50 million in funding, two years after securing $140 million in Series C funding.
Temasek led the funding with participation from existing investors Sofina, ICONIQ Growth, Helena, and Peak XV.
WHAT IT DOES
Twin’s product is the Whole Body Digital Twin, an AI-backed model that aims to provide individualized nutrition, sleep and...
AI in healthcare and value-based care enablement are top developing trends in healthcare, but lack scalability so far, while big box retailers as providers and data interoperability have shown a high volume of activity in 2023, and are scaling with long-term trajectories.
Rock Health's report, which utilized data to determine the sequence of developments in the digital health space this year,...
At-home fertility care company Mosie Baby announced it received FDA 510(k) clearance for the first over-the-counter intravaginal insemination (IVI) kit, which allows individuals to perform at-home insemination using either a fresh or cryogenically frozen donor semen sample.
Mosie's home insemination kit includes two syringes with a barrel-free tip and a slit opening, as well as two collection...
Today, a tale of two markets are seen in healthcare mergers and acquisition: the present (as reflected in the data about declining dealmaking) and the future (reflected in the increasingly positive outlook by dealmakers).
While deal data can vary according to how it is defined and who is reporting, it has declined substantially across the board since the high-water mark in late 2021 and early...
Leaders in the digital health space relayed to MobiHealthNews what stood out to them in 2023 as the year draws to an end.
Many noted the meteoric rise of genAI in 2023 and expectations of growing adoption of the technology in 2024, emphasizing the importance of treading carefully as the tech is further implemented. Other stakeholders pinpointed bankruptcies and mergers and acquisitions as being...
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.
The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates...
Value-based care provider NuvoAir is partnering with the ALS Association to provide virtual pulmonary care to individuals with ALS, starting with two clinics in Texas.
ALS is a nervous system disorder that affects motor neurons, which are nerve cells in the spinal cord and brain that control breathing and voluntary muscle movement. Individuals with ALS often experience respiratory complications...
Dr. Michael Howell, chief clinical officer at Google, sat down with MobiHealthNews to discuss noteworthy events in 2023, the evolution of the company's LLM for healthcare, called Med-PaLM, and recommendations for regulators in constructing rules around the use of artificial intelligence in the sector.
MobiHealthNews: What are some of your big takeaways from 2023?
Dr. Michael Howell: For us,...